Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    13%
    Check dated 2025-10-05T17:29:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, signaling a new release/version without altering core content or critical data.
    Difference
    0.3%
    Check dated 2025-09-28T10:48:58.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 instead of v3.0.1, and the Back to Top element was removed; overall content remains essentially the same.
    Difference
    0.8%
    Check dated 2025-09-14T00:38:25.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The recruitment status for Actinium Pharmaceuticals has been updated to 'Unknown status', indicating a significant change in the information provided about the clinical trial. Additionally, the version of the document has been revised from v3.0.0 to v3.0.1.
    Difference
    3%
    Check dated 2025-09-06T21:27:09.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while removing specific location details and previous status verifications.
    Difference
    12%
    Check dated 2025-08-30T15:58:59.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-08-16T12:47:36.000Z thumbnail image

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.